Keefe, Bruyette & Woods Downgrades Crescent Capital BDC to Market Perform, Lowers Price Target to $12

Benzinga Newsdesk www.benzinga.com Negative 94.5%

Neg 94.5% Neu 0% Pos 0%

Keefe, Bruyette & Woods analyst Paul Johnson downgrades Crescent Capital BDC (NASDAQ:CCAP) from Outperform to Market Perform and lowers the price target from $13 to $12.